Summary for 2X9D
Entry DOI | 10.2210/pdb2x9d/pdb |
Related | 1A6I 1BJ0 1BJY 1BJZ 1DU7 1ORK 1QPI 2TCT 2TRT 2VKE 2VKV 2X6O 2XB5 2XGC 2XGD 2XGE 2XPS 2XPT 2XPU 2XPV 2XPW 2XRL |
Descriptor | TETRACYCLINE REPRESSOR PROTEIN CLASS D, ISO-7-CHLORTETRACYCLINE, CHLORIDE ION, ... (4 entities in total) |
Functional Keywords | transcription, gene regulation, hth-motif, dna-binding protein, antibiotic resistance |
Biological source | ESCHERICHIA COLI |
Total number of polymer chains | 1 |
Total formula weight | 23909.03 |
Authors | Volkers, G.,Hinrichs, W. (deposition date: 2010-03-15, release date: 2011-03-23, Last modification date: 2023-12-20) |
Primary citation | Volkers, G.,Petruschka, L.,Hinrichs, W. Recognition of Drug Degradation Products by Target Proteins: Isotetracycline Binding to Tet Repressor. J.Med.Chem., 54:5108-, 2011 Cited by PubMed Abstract: Tetracycline antibiotics and their degradation products appear in medically treated tissues, food, soil, and manure sludge in the environment. In the context of protein interactions with various tetracyclines we performed crystal structure analyses of the tetracycline repressor in complex with weak or noninducing tetracycline derivatives. Isotetracyclines are degradation products of tetracyclines, which occur under physiological conditions. The typical framework of the antibiotic is irreversibly broken at the BC-ring connection, leading to a modified orientation of the AB to the new C*D ring fragments. The shape of the zwitterionic AB-ring fragment is unchanged and still binds to the TetR recognition site in a manner comparable to the intact antibiotic but without typical Mg(2+) chelation. This work is an example that drug degradation products can still bind to specific targets and should be discussed in light of potential and critical side effects. PubMed: 21699184DOI: 10.1021/JM200332E PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.34 Å) |
Structure validation
Download full validation report
